Patents by Inventor Thomas A. Andresen

Thomas A. Andresen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240108844
    Abstract: A humidification system can include a heater base, a humidification chamber, and a breathing circuit. A cartridge can be removably coupled to the heater base. The cartridge can include various sensors, probes, sensor wire connectors, heater wire connectors, and/or other features. The cartridge can include features configured to mate with corresponding features on the humidification chamber and the heater base. The cartridge includes a memory, such as an EEPROM, or other suitable storage device. When the cartridge is installed on the heater base, the memory is electrically connected to a processor and/or memory of the heater base. Various models of cartridges can be produced for use with different humidification chambers, breathing circuits, and/or therapies. A connector can be configured to couple an inspiratory conduit to an outlet port of the humidification chamber. The connector can provide a pneumatic connection to the outlet port and an electrical connection to the cartridge.
    Type: Application
    Filed: September 20, 2023
    Publication date: April 4, 2024
    Inventors: Hamish Adrian OSBORNE, Gavin Walsh Millar, Stephen David Evans, Bruce Gordon Holyoake, James William Stanton, David Leon McCauley, Gareth Thomas McDermott, Nicholas James Michael McKenna, Myfanwy Jane Antica Norton, Adrian John Elsworth, Michael John Andresen, Jonathan Andrew George Lambert, Sandeep Singh Gurm, Tessa Hazel Paris, Joseph Nathaniel Griffiths, Ping Si, Christopher Gareth Sims, Elmo Benson Stoks, Dexter Chi Lun Cheung, Peter Alan Seekup, Po-Yen Liu, Richard Edward Lang, Paul James Tonkin, Ian Lee Wai Kwan
  • Publication number: 20220411636
    Abstract: The invention concerns a method for the preparation of a bituminous composition BC comprising the following steps: a) having an intermediary hydrocarbonated composition IC comprising: a hydrocarbonated component selected among bitumen and oils, and a hydroxide XOH with X=Na or K, which represents from 15 to 50% by weight of the total weight of the intermediary hydrocarbonated composition IC, b) introducing the intermediary hydrocarbonated composition IC, into a composition HC of a bitumen, in particular chosen among paving grade bitumen as defined by EN 12591 and polymer modified bitumen as defined by EN 14023. The intermediary hydrocarbonated composition IC as defined in the invention and its uses are other aspects of the invention.
    Type: Application
    Filed: December 10, 2020
    Publication date: December 29, 2022
    Applicant: TOTALENERGIES ONETECH
    Inventors: Stefan OEST, Soenke SCHROEDER, Thomas ANDRESEN
  • Patent number: 11331396
    Abstract: Radiation therapy or radiotherapy (RT) is a powerful treatment where precision and accuracy is crucial. Image Guided Radiotherapy (IGRT) facilitates more accurate position verification, correcting for anatomic changes related to internal organ movement. IGRT thereby helps reduce toxicity of radiotherapy and increases relapse-free survival. An inter-correlation point with a fixed position and volume (a marker) can be applied to indicate the point of treatment clearly in both imaging modalities and to localize and track tumors in real time. In this study, we present the development of a marker based on lactose octaacetate:octapropionate 1:1 containing 3 mM PLA-DTPA(Gd), 40% triglyceride, 5% propylene carbonate and 10% XSAIB (sucrose based CT-contrast agent). The injectable marker had high CT contrast (>1000 HU) and displayed clearly visible, stable T1 contrast enhancement (T1˜900 ms) in the rim over at least 3 weeks with clinically observable resolution.
    Type: Grant
    Filed: May 24, 2018
    Date of Patent: May 17, 2022
    Assignees: TECHNICAL UNIVERSITY OF DENMARK, NANOVI RADIOTHERAPY APS
    Inventors: Thomas Andresen, Rasmus Irming Jølck, Linda Maria Bruun
  • Publication number: 20210115255
    Abstract: The invention concerns bituminous compositions comprising: a bitumen, a hydroxide XOH, with X=Na, Ca, Mg, Li or K, and at least one amine additive selected from amines, diamines, polyamines, alkyl amido amines, amidopolyamines and imidazolines, wherein said bituminous composition is substantially free of saponifiable and saponified carboxylic acids, meaning that, if present, the weight of saponifiable and saponified carboxylic acids represents at most 0.01% of the total weight of said bituminous composition and the bitumen represents at least 60% by weight of said bituminous composition, their preparation process and their use in road applications.
    Type: Application
    Filed: May 7, 2018
    Publication date: April 22, 2021
    Applicant: TOTAL MARKETING SERVICES
    Inventors: Thomas ANDRESEN, Stefan OEST, Soenke SCHROEDER
  • Patent number: 10937249
    Abstract: The present disclosure provides systems and methods that allow a first user to anchor a virtual object to a physical location and a second user to view the virtual object at the physical location. In particular, aspects of the present disclosure are directed to workflows, application programming interfaces (“APIs”), and computing system infrastructure that enable a first computing device to generate an ad hoc mapping of its physical surroundings (e.g., based on sensor data collected by the first device) and to position and anchor a virtual object at a physical location within such mapping. Data descriptive of the mapping and virtual object can be stored in a cloud database and can then be used by or for a second device to render the virtual object at the location of the anchor.
    Type: Grant
    Filed: May 7, 2019
    Date of Patent: March 2, 2021
    Assignee: Google LLC
    Inventors: Simon Lynen, Eric Thomas Andresen
  • Publication number: 20200222560
    Abstract: Radiation therapy or radiotherapy (RT) is a powerful treatment where precision and accuracy is crucial. Image Guided Radiotherapy (IGRT) facilitates more accurate position verification, correcting for anatomic changes related to internal organ movement. IGRT thereby helps reduce toxicity of radiotherapy and increases relapse-free survival. An inter-correlation point with a fixed position and volume (a marker) can be applied to indicate the point of treatment clearly in both imaging modalities and to localize and track tumors in real time. In this study, we present the development of a marker based on lactose octaacetate:octapropionate 1:1 containing 3 mM PLA-DTPA(Gd), 40% triglyceride, 5% propylene carbonate and 10% XSAIB (sucrose based CT-contrast agent). The injectable marker had high CT contrast (>1000 HU) and displayed clearly visible, stable T1 contrast enhancement (T1˜0.900 ms) in the rim over at least 3 weeks with clinically observable resolution.
    Type: Application
    Filed: May 24, 2018
    Publication date: July 16, 2020
    Inventors: Thomas Andresen, Rasmus Irming Jølck, Linda Maria Bruun
  • Publication number: 20190340836
    Abstract: The present disclosure provides systems and methods that allow a first user to anchor a virtual object to a physical location and a second user to view the virtual object at the physical location. In particular, aspects of the present disclosure are directed to workflows, application programming interfaces (“APIs”), and computing system infrastructure that enable a first computing device to generate an ad hoc mapping of its physical surroundings (e.g., based on sensor data collected by the first device) and to position and anchor a virtual object at a physical location within such mapping. Data descriptive of the mapping and virtual object can be stored in a cloud database and can then be used by or for a second device to render the virtual object at the location of the anchor.
    Type: Application
    Filed: May 7, 2019
    Publication date: November 7, 2019
    Inventors: Simon Lynen, Eric Thomas Andresen
  • Patent number: 8081629
    Abstract: The benefits of a multicast-enabled network are realized by a flexible, easy to deploy, software-based solution that does not require reconfiguring of network routers. Systems and methods that implement this solution can perform as follows. A packet is received that was sent by a sender to at least one receiver, and the packet includes a parameter relating to a multicast announce address. A forwarding rules set is associated with the packet if the parameter has a defined value. This forwarding rules set is used to determine whether any of the at least one destination addresses included in the packet corresponds to one of the receivers that has a receiver format that must be converted. In addition, the forwarding rules set defines when a packet should be converted from a sender format to a receiver format before forwarding the packet.
    Type: Grant
    Filed: April 19, 2010
    Date of Patent: December 20, 2011
    Assignee: Darby & Mohaine, L.L.C.
    Inventors: C. Kenneth Miller, Thomas Andresen, Thomas Gardner, Craig Michelson, Kenneth Cates, Marc White, Kary Robertson
  • Publication number: 20100202454
    Abstract: The benefits of a multicast-enabled network are realized by a flexible, easy to deploy, software-based solution that does not require reconfiguring of network routers. Systems and methods that implement this solution can perform as follows. A packet is received that was sent by a sender to at least one receiver, and the packet includes a parameter relating to a multicast announce address. A forwarding rules set is associated with the packet if the parameter has a defined value. This forwarding rules set is used to determine whether any of the at least one destination addresses included in the packet corresponds to one of the receivers that has a receiver format that must be converted. In addition, the forwarding rules set defines when a packet should be converted from a sender format to a receiver format before forwarding the packet.
    Type: Application
    Filed: April 19, 2010
    Publication date: August 12, 2010
    Inventors: C. Kenneth Miller, Thomas Andresen, Thomas Gardner, Craig Michelson, Kenneth Cates, Marc White, Kary Robertson
  • Patent number: 7710961
    Abstract: The benefits of a multicast-enabled network are realized by a flexible, easy to deploy, software-based solution that does not require reconfiguring of network routers. Systems and methods that implement this solution can perform as follows. A packet is received that was sent by a sender to at least one receiver, and the packet includes a parameter relating to a multicast announce address. A forwarding rules set is associated with the packet if the parameter has a defined value. This forwarding rules set is used to determine whether any of the at least one destination addresses included in the packet corresponds to one of the receivers that has a receiver format that must be converted. In addition, the forwarding rules set defines when a packet should be converted from a sender format to a receiver format before forwarding the packet.
    Type: Grant
    Filed: October 1, 2004
    Date of Patent: May 4, 2010
    Inventors: C. Kenneth Miller, Thomas Andresen, Thomas Gardner, Craig Michelson, Kenneth Cates, Marc White, Kary Robertson
  • Publication number: 20080014253
    Abstract: The present invention relates to a lipid-based drug delivery system for administration of a lysolipid derivative present in a prodrug from, said prodrug furthermore being a substrate for extracellular phospholipase A2 to the extent that an organic radical can be hydrolytically cleaved off, whereas the aliphatic group of the lysolipid derivative remains substantially unaffected, said system having included therein lipopolymers or glycolipids so as to present hydrophilic chains on the surface of the system. Particularly interesting lipid derivatives are lipids in which the head group is linked to the C-2 position and the organic radical (a drug substance) is covalently attached to the C-3 position of the glycerol moiety. Pharmaceutical compositions comprising the drug delivery system can be used in diagnosis and targeted treatment of various disorders, e.g. cancer, infectious, and inflammatory conditions, etc., i.e.
    Type: Application
    Filed: November 3, 2005
    Publication date: January 17, 2008
    Inventors: Kent Jorgensen, Thomas Andresen
  • Publication number: 20050100016
    Abstract: The benefits of a multicast-enabled network are realized by a flexible, easy to deploy, software-based solution that does not require reconfiguring of network routers. Systems and methods that implement this solution can perform as follows. A packet is received that was sent by a sender to at least one receiver, and the packet includes a parameter relating to a multicast announce address. A forwarding rules set is associated with the packet if the parameter has a defined value. This forwarding rules set is used to determine whether any of the at least one destination addresses included in the packet corresponds to one of the receivers that has a receiver format that must be converted. In addition, the forwarding rules set defines when a packet should be converted from a sender format to a receiver format before forwarding the packet.
    Type: Application
    Filed: October 1, 2004
    Publication date: May 12, 2005
    Applicant: The Fantastic Corporation
    Inventors: C. Miller, Thomas Andresen, Thomas Gardner, Craig Michelson, Kenneth Cates, Marc White, Kary Robertson
  • Patent number: 6873627
    Abstract: The benefits of a multicast-enabled network are realized by a flexible, easy to deploy, software-based solution that does not require reconfiguring of network routers. Systems and methods that implement this solution can perform as follows. A packet is received that was sent by a sender to at least one receiver, and the packet includes a parameter relating to a multicast announce address. A forwarding rules set is associated with the packet if the parameter has a defined value. This forwarding rules set is used to determine whether any of the at least one destination addresses included in the packet corresponds to one of the receivers that has a receiver format that must be converted. In addition, the forwarding rules set defines when a packet should be converted from a sender format to a receiver format before forwarding the packet.
    Type: Grant
    Filed: July 30, 1999
    Date of Patent: March 29, 2005
    Assignee: The Fantastic Corporation
    Inventors: C. Kenneth Miller, Thomas Andresen, Thomas Gardner, Craig Michelson, Kenneth Cates, Marc White, Kary Robertson
  • Patent number: D646541
    Type: Grant
    Filed: November 4, 2010
    Date of Patent: October 11, 2011
    Inventor: Thomas A. Andresen